Comments
Loading...
Verastem (VSTM) Forecast
NewsEarningsVerastem (VSTM) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVerastem (NASDAQ:VSTM) Stock Quotes, Forecast and News Summary
Verastem Stock (NASDAQ: VSTM) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Verastem (VSTM) stock?
You can purchase shares of Verastem (NASDAQ:VSTM) through any online brokerage.
Who are Verastem (VSTM) competitors?
Other companies in Verastem’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Monopar Therapeutics (NASDAQ:MNPR), Korro Bio (NASDAQ:KRRO) and Larimar Therapeutics (NASDAQ:LRMR).
What is the forecast, or price target, for Verastem (VSTM) stock?
Verastem has a consensus price target of $15.78.
What is the current price for Verastem (VSTM)?
The stock price for Verastem (NASDAQ: VSTM) is $5.71 last updated February 21, 2025 at 10:41 AM EST.
Does Verastem (VSTM) pay a dividend?
There are no upcoming dividends for Verastem.
When is Verastem (NASDAQ:VSTM) reporting earnings?
Verastem’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Verastem (VSTM) going to split?
There is no upcoming split for Verastem.
What sector and industry does Verastem (VSTM) operate in?
Verastem is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.